PDF herunterladen
Thorac Cardiovasc Surg 2012; 60(06): 405-412
DOI: 10.1055/s-0031-1299584
Original Thoracic
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Role of Residual Tumor Resection in the Management of Nonseminomatous Germ Cell Cancer of Testicular Origin

Authors

  • Joachim Schirren

    1   Department of Thoracic Surgery, Dr. Horst Schmidt Klinik, Wiesbaden, Germany

  • Stephan Trainer

    1   Department of Thoracic Surgery, Dr. Horst Schmidt Klinik, Wiesbaden, Germany

  • Michael Eberlein

    2   Division of Pulmonary, Critical Care, and Occupational Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, United States

  • Anja Lorch

    3   Departments of Hematology and Oncology, Universitätsklinikum Giessen und Marburg GmbH, Marburg, Germany

  • Jörg Beyer

    4   Departments of Hematology and Oncology, Vivantes Klinikum Am Urban, Berlin, Germany

  • Servet Bölükbas

    1   Department of Thoracic Surgery, Dr. Horst Schmidt Klinik, Wiesbaden, Germany
Weitere Informationen

Publikationsverlauf

26. August 2011

07. November 2011

Publikationsdatum:
01. März 2012 (online)

   Lizenzen und Reprints Alle Artikel dieser Rubrik
Preview

Abstract

Objective To assess the outcome of patients with testicular nonseminomatous germ cell tumors (TNSGCT) undergoing intrathoracic residual tumor resection (RTR) after previous chemotherapy (CT) at a single institution.

Methods The office records of all patients who underwent intrathoracic RTR for TNSGCT after CT at a single institution from January 2000 through December 2006 were reviewed.

Results There were 124 consecutive patients (age 33.1 ± 8.4 years) with residual masses who underwent 189 surgical procedures. Morbidity and mortality rates were 12.7 and 0.5%, respectively. Complete resections could be achieved in 121 patients (97.6%). In the resected lung masses, necrosis was the predominant histology, (44.4 vs. 29% in mediastinal masses p = 0.018). Mature teratoma was the leading histology in the mediastinum (62.1 vs. 39.5% in lung masses, p = 0.0006). Fifty-nine out of 124 patients (47.6%) required interventions at both lungs and had discordant histological results in 20.3% (12/59) of the cases. Mean survival was 86.6 ± 2.6 months. The overall 5-year-survival and 10-year survival rates were 87 and 85%, respectively. Viable cancer, incomplete resections, age ≥34 years, and major pulmonary resections were associated with inferior survival in a univariate Cox proportional hazards model. In a multivariable Cox proportional hazards model, viable cancer, incomplete resections, and major pulmonary resections remained significant prognostic factors.

Conclusions In selected TNSGCT patients with residual masses, RTR can be performed safely after CT. RTR should be attempted at all sites because of possible discordant histological differentiation. Complete and parenchyma-sparing resections are associated with excellent long-term survival, which can be influenced by the surgeon.

Keywords

germ cell tumor - pulmonary metastasectomy - residual mass - chemotherapy - metastases
 

  • References

  • 1 Schmoll HJ, Souchon R, Krege S , et al; European Germ Cell Cancer Consensus Group. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15 (9) 1377-1399
    CrossrefPubMedSuche in Google Scholar
  • 2 Steyerberg EW, Keizer HJ, Fosså SD , et al. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol 1995; 13 (5) 1177-1187
    PubMedSuche in Google Scholar
  • 3 Sonneveld DJ, Sleijfer DT, Koops HS, Keemers-Gels ME, Molenaar WM, Hoekstra HJ. Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach. Cancer 1998; 82 (7) 1343-1351
    CrossrefPubMedSuche in Google Scholar
  • 4 Fizazi K, Tjulandin S, Salvioni R , et al. Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy—results from an International Study Group. J Clin Oncol 2001; 19: 2647-2657
    PubMedSuche in Google Scholar
  • 5 Gerl A, Clemm C, Schmeller N , et al. Outcome analysis after post-chemotherapy surgery in patients with non-seminomatous germ cell tumours. Ann Oncol 1995; 6 (5) 483-488
    PubMedSuche in Google Scholar
  • 6 Vogt-Moykopf I, Krysa S, Bülzebruck H, Schirren J. Surgery for pulmonary metastases. The Heidelberg experience. Chest Surg Clin N Am 1994; 4 (1) 85-112
    PubMedSuche in Google Scholar
  • 7 Schirren J, Bergmann T, Beqiri S, Bölükbas S, Fisseler-Eckhoff A, Vogt-Moykopf I. Lymphatic spread in resectable lung cancer: can we trust in a sentinel lymph node?. Thorac Cardiovasc Surg 2006; 54 (6) 373-380
    Thieme ConnectPubMedSuche in Google Scholar
  • 8 International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997; 15 (2) 594-603
    CrossrefPubMedSuche in Google Scholar
  • 9 Liu D, Abolhoda A, Burt ME , et al. Pulmonary metastasectomy for testicular germ cell tumors: a 28-year experience. Ann Thorac Surg 1998; 66 (5) 1709-1714
    CrossrefPubMedSuche in Google Scholar
  • 10 Kesler KA, Donohue JP. Combined urologic and thoracic approaches for advanced or disseminated testis cancer. Atlas Urologic Clin N Am 1999; 7: 79-94
    PubMedSuche in Google Scholar
  • 11 Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med 1997; 337 (4) 242-253
    CrossrefPubMedSuche in Google Scholar
  • 12 Oechsle K, Hartmann M, Brenner W , et al; German Multicenter Positron Emission Tomography Study Group. [18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group. J Clin Oncol 2008; 26 (36) 5930-5935
    CrossrefPubMedSuche in Google Scholar
  • 13 Pfannenberg C, Aschoff P, Dittmann H , et al. PET/CT with 18F-FLT: does it improve the therapeutic management of metastatic germ cell tumors?. J Nucl Med 2010; 51 (6) 845-853
    CrossrefPubMedSuche in Google Scholar
  • 14 Mandelbaum I, Yaw PB, Einhorn LH, Williams SD, Rowland RG, Donohue JP. The importance of one-stage median sternotomy and retroperitoneal node dissection in disseminated testicular cancer. Ann Thorac Surg 1983; 36 (5) 524-528
    CrossrefPubMedSuche in Google Scholar
  • 15 Brenner PC, Herr HW, Morse MJ , et al. Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis. J Clin Oncol 1996; 14 (6) 1765-1769
    PubMedSuche in Google Scholar
  • 16 Tiffany P, Morse MJ, Bosl GH , et al. Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy for stage III germ cell tumors. Cancer 1986; 57 (5) 978-983
    CrossrefPubMedSuche in Google Scholar
  • 17 Qvist HL, Fosså SD, Ous S, Høie J, Stenwig AE, Giercksky KE. Post-chemotherapy tumor residuals in patients with advanced nonseminomatous testicular cancer. Is it necessary to resect all residual masses?. J Urol 1991; 145 (2) 300-302, discussion 302–303
    PubMedSuche in Google Scholar
  • 18 Besse B, Grunenwald D, Fléchon A , et al. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis. J Thorac Cardiovasc Surg 2009; 137 (2) 448-452
    CrossrefPubMedSuche in Google Scholar
  • 19 Rick O, Bokemeyer C, Weinknecht S , et al. Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer. J Clin Oncol 2004; 22 (18) 3713-3719
    CrossrefPubMedSuche in Google Scholar
  • 20 Andrade RS, Kesler KA, Wilson JL , et al. Short- and long-term outcomes after large pulmonary resection for germ cell tumors after bleomycin-combination chemotherapy. Ann Thorac Surg 2004; 78 (4) 1224-1228, discussion 1228–1229
    CrossrefPubMedSuche in Google Scholar
  • 21 Skinner DG, Melamud A, Lieskovsky G. Complications of thoracoabdominal retroperitoneal lymph node dissection. J Urol 1982; 127 (6) 1107-1110
    PubMedSuche in Google Scholar
  • 22 Kesler KA, Brooks JA, Rieger KM, Fineberg NS, Einhorn LH, Brown JW. Mediastinal metastases from testicular nonseminomatous germ cell tumors: patterns of dissemination and predictors of long-term survival with surgery. J Thorac Cardiovasc Surg 2003; 125 (4) 913-923
    CrossrefPubMedSuche in Google Scholar
  • 23 Cagini L, Nicholson AG, Horwich A, Goldstraw P, Pastorino U. Thoracic metastasectomy for germ cell tumours: long term survival and prognostic factors. Ann Oncol 1998; 9 (11) 1185-1191
    CrossrefPubMedSuche in Google Scholar
  • 24 Fizazi K, Prow DM, Do KA , et al. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours. Br J Cancer 2002; 86 (10) 1555-1560
    CrossrefPubMedSuche in Google Scholar
  • 25 Pfannschmidt J, Zabeck H, Muley T, Dienemann H, Hoffmann H. Pulmonary metastasectomy following chemotherapy in patients with testicular tumors: experience in 52 patients. Thorac Cardiovasc Surg 2006; 54 (7) 484-488
    Thieme ConnectPubMedSuche in Google Scholar
  • 26 Kesler KA, Wilson JL, Cosgrove JA , et al. Surgical salvage therapy for malignant intrathoracic metastases from nonseminomatous germ cell cancer of testicular origin: analysis of a single-institution experience. J Thorac Cardiovasc Surg 2005; 130 (2) 408-415
    CrossrefPubMedSuche in Google Scholar